International Legal Practice of Material Transfer Agreements: A Comparative Legal Analysis

This comparative legal analysis examines international practices governing Material Transfer Agreements in biotechnology across four major jurisdictions: the United States, the European Union, Japan, and China. Through a systematic doctrinal methodology and functional comparison, the study analyzes the evolution of regulations, contractual frameworks, and intellectual property regimes. Results reveal significant jurisdictional variations in balancing innovation, biosecurity, and equity. American market pragmatism, as exemplified by the UBMTA standardization, contrasts with European precautionary harmonization, Japanese relationship-based cooperation, and Chinese sovereignty-focused frameworks. Findings demonstrate persistent divergences despite the universal recognition of the importance of biosafety, intellectual property, and benefit sharing. These insights inform the development of effective MTA frameworks in developing countries, which balance competing objectives.